Free Trial

Relx Plc (NYSE:RELX) Short Interest Update

Relx logo with Computer and Technology background

Key Points

  • Relx Plc's short interest decreased significantly by 47.2% in September, falling to 1,120,000 shares from 2,120,000 shares in August, indicating lower bearish sentiment among investors.
  • The company declared a semi-annual dividend of $0.2634 per share, which represents a yield of 170.0%, amid an ongoing dividend payout ratio of 27.96%.
  • Multiple analysts have varied ratings on Relx, with Kepler Capital Markets upgrading the stock to a strong-buy, while Wall Street Zen lowered its rating to hold, reflecting mixed outlooks on the company’s performance.
  • Five stocks we like better than Relx.

Relx Plc (NYSE:RELX - Get Free Report) was the recipient of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 1,120,000 shares, a drop of 47.2% from the August 31st total of 2,120,000 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is presently 0.9 days. Based on an average trading volume of 1,310,000 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.1% of the shares of the company are short sold.

Hedge Funds Weigh In On Relx

A number of hedge funds have recently bought and sold shares of RELX. Wealth Enhancement Advisory Services LLC increased its position in Relx by 12.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 46,476 shares of the technology company's stock worth $2,111,000 after acquiring an additional 5,081 shares during the period. Rhumbline Advisers increased its position in Relx by 1.2% during the first quarter. Rhumbline Advisers now owns 34,906 shares of the technology company's stock worth $1,760,000 after acquiring an additional 411 shares during the period. Merit Financial Group LLC grew its stake in Relx by 77.7% during the first quarter. Merit Financial Group LLC now owns 11,757 shares of the technology company's stock worth $593,000 after buying an additional 5,139 shares in the last quarter. Blue Zone Wealth Advisors LLC grew its stake in Relx by 11.0% during the first quarter. Blue Zone Wealth Advisors LLC now owns 123,841 shares of the technology company's stock worth $6,243,000 after buying an additional 12,303 shares in the last quarter. Finally, Sivia Capital Partners LLC acquired a new stake in Relx during the first quarter worth about $224,000. 15.02% of the stock is owned by institutional investors.

Relx Stock Performance

NYSE:RELX traded down $0.18 during mid-day trading on Friday, reaching $46.43. 1,064,803 shares of the company's stock were exchanged, compared to its average volume of 1,283,989. Relx has a one year low of $44.19 and a one year high of $56.33. The firm has a market capitalization of $85.09 billion, a PE ratio of 24.96, a price-to-earnings-growth ratio of 3.04 and a beta of 0.87. The business's fifty day simple moving average is $47.85 and its two-hundred day simple moving average is $50.95. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47.

Relx Cuts Dividend

The firm also recently declared a semi-annual dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 8th were given a dividend of $0.2634 per share. This represents a yield of 170.0%. The ex-dividend date of this dividend was Friday, August 8th. Relx's dividend payout ratio (DPR) is currently 27.96%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Kepler Capital Markets raised shares of Relx from a "hold" rating to a "strong-buy" rating in a research report on Thursday, September 18th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Thursday, September 11th. Wall Street Zen lowered shares of Relx from a "buy" rating to a "hold" rating in a research report on Friday, September 5th. Finally, Weiss Ratings reissued a "buy (b)" rating on shares of Relx in a research report on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. According to MarketBeat, Relx has a consensus rating of "Buy".

Check Out Our Latest Stock Analysis on Relx

Relx Company Profile

(Get Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.